Revance Therapeutics Inc (NASDAQ:RVNC)

31.47
Delayed Data
As of Mar 23
 -0.31 / -0.98%
Today’s Change
11.27
Today|||52-Week Range
36.61
+70.48%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close31.78
Today’s open32.05
Day’s range31.08 - 32.87
Volume26,738
Average volume (3 months)1,450,297
Market cap$2.6B
Data as of 4:00pm ET, 03/23/2023

Growth & Valuation

Earnings growth (last year)-17.63%
Earnings growth (this year)+18.61%
Earnings growth (next 5 years)+192.00%
Revenue growth (last year)+70.40%
P/E ratioNM
Price/Sales10.13
Price/Book203.94

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.31-0.83%
HCMHUTCHMED (China) Ltd-0.37-2.54%
BHCValeant Pharmaceutic...-0.30-3.96%
SAGESAGE Therapeutics In...+0.40+0.95%
Data as of 4:00pm ET, 03/23/2023

Financials

Next reporting dateMay 9, 2023
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$132.6M
Annual profit (last year)-$356.4M
Net profit margin-268.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts